October 29, 2020
CMS issues coverage plan for COVID-19 vaccines, treatments
Editor's Note
The Centers for Medicare and Medicaid Services (CMS) on October 28 issued an interim final rule that requires CMS to cover any COVID-19 vaccines that receive Food and Drug Administration (FDA) authorization at no cost to beneficiaries.
The rule also will increase what Medicare pays hospitals for COVID-19 treatments.
Workplace and individual health insurance plans will cover the vaccine as a preventive service, with no cost sharing.
The regulations are effective immediately, with a 30-day comment period.
Free Daily News
- Market volatility threatens hospitals’ liquidity as tariff-driven costs rise
- Study: CT scan radiation could drive 5% of future cancer cases
- New studies, surgical feats advance organ transplant medicine
- Commentary: Cyberattacks threaten financial survival of surgical practices
- Tariffs strain supply chains, split medical manufacturing community
- Study: Systemic gender bias embedded in surgical practice
- Literature review: Endoscope disinfection failures highlight need for stronger sterilization practices
- Study: GLP-1 drugs heighten risk of gastric residue but not perioperative pulmonary aspiration
- OAS CAHPS compliance soars to 96% among ASCs, vendor satisfaction also improves
- Knee surgical robot market set to surge, projected to reach $5.9B by 2032
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement